Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 22

1.

Pompe's disease.

van der Ploeg AT, Reuser AJ.

Lancet. 2008 Oct 11;372(9646):1342-53. doi: 10.1016/S0140-6736(08)61555-X. Review.

PMID:
18929906
2.

Late-onset Pompe's disease.

Teener JW.

Semin Neurol. 2012 Nov;32(5):506-11. doi: 10.1055/s-0033-1334469. Epub 2013 May 15. Review.

PMID:
23677658
3.

The natural course of non-classic Pompe's disease; a review of 225 published cases.

Winkel LP, Hagemans ML, van Doorn PA, Loonen MC, Hop WJ, Reuser AJ, van der Ploeg AT.

J Neurol. 2005 Aug;252(8):875-84. Review.

PMID:
16133732
4.

Glycogenosis type II (acid maltase deficiency).

Reuser AJ, Kroos MA, Hermans MM, Bijvoet AG, Verbeet MP, Van Diggelen OP, Kleijer WJ, Van der Ploeg AT.

Muscle Nerve Suppl. 1995;3:S61-9. Review.

PMID:
7603530
5.

[Pompe's disease. Part I: pathogenesis and clinical features].

Illés Z, Trauninger A.

Ideggyogy Sz. 2009 Jul 30;62(7-8):231-43. Review. Hungarian.

PMID:
19685701
6.

[Pompe's disease. Part II. Treatment strategies and enzyme replacement].

Illés Z, Várdi Visy K.

Ideggyogy Sz. 2009 Sep 30;62(9-10):299-307. Review. Hungarian.

PMID:
19835271
7.

The natural course of infantile Pompe's disease: 20 original cases compared with 133 cases from the literature.

van den Hout HM, Hop W, van Diggelen OP, Smeitink JA, Smit GP, Poll-The BT, Bakker HD, Loonen MC, de Klerk JB, Reuser AJ, van der Ploeg AT.

Pediatrics. 2003 Aug;112(2):332-40. Review.

PMID:
12897283
8.

Cardiomyopathy in Pompe's disease.

Fayssoil A.

Eur J Intern Med. 2008 Jan;19(1):57-9. doi: 10.1016/j.ejim.2007.09.018. Epub 2007 Nov 26. Review.

PMID:
18206603
9.

Two eminently treatable genetic metabolic myopathies.

Yee WC.

Neurol India. 2008 Jul-Sep;56(3):333-8. Review.

10.

Pompe disease (glycogen storage disease type II): clinical features and enzyme replacement therapy.

van der Beek NA, Hagemans ML, van der Ploeg AT, Reuser AJ, van Doorn PA.

Acta Neurol Belg. 2006 Jun;106(2):82-6. Review.

PMID:
16898258
11.

Glycogen storage disease type II in the Lapland dog.

Walvoort HC.

Vet Q. 1985 Jul;7(3):187-90. Review.

PMID:
3901497
12.

[Pompe's disease--acid alpha-glucosidase deficiency--a review].

Iwamasa T, Chinen K, Hirayasu T.

Nihon Rinsho. 1993 Sep;51(9):2324-9. Review. Japanese.

PMID:
8411709
13.

Two cases of Pompe's disease: case report and review of literature.

Jegadeeswari A, Amuthan V, Janarthanan RA, Murugan S, Balasubramanian S.

Indian Heart J. 2012 Mar-Apr;64(2):214-6. doi: 10.1016/S0019-4832(12)60067-4. Epub 2012 Apr 28. Review.

14.

Enzyme therapy for Pompe disease: from science to industrial enterprise.

Reuser AJ, Van Den Hout H, Bijvoet AG, Kroos MA, Verbeet MP, Van Der Ploeg AT.

Eur J Pediatr. 2002 Oct;161 Suppl 1:S106-11. Epub 2002 Aug 13. Review.

PMID:
12373583
15.

Pompe disease: a review of the current diagnosis and treatment recommendations in the era of enzyme replacement therapy.

Katzin LW, Amato AA.

J Clin Neuromuscul Dis. 2008 Jun;9(4):421-31. doi: 10.1097/CND.0b013e318176dbe4. Review.

PMID:
18525427
16.

alpha-Glucosidase deficiency (Pompe's disease).

Tager JM, Oude Elferink RP, Reuser A, Kroos M, Ginsel LA, Fransen JA, Klumperman J.

Enzyme. 1987;38(1-4):280-5. Review.

PMID:
3126044
17.

Acid alpha-glucosidase deficiency (glycogenosis type II, Pompe disease).

Raben N, Plotz P, Byrne BJ.

Curr Mol Med. 2002 Mar;2(2):145-66. Review.

PMID:
11949932
18.

Laboratory diagnosis of the neuromuscular glycogen storage diseases.

Farmer PM.

Ann Clin Lab Sci. 1982 Nov-Dec;12(6):431-8. Review.

PMID:
6817693
19.

Acid maltase deficiency--Pompe's disease.

Jamil S, Ahmed S, Tariq M.

J Pak Med Assoc. 2011 Aug;61(8):821-3. Review.

20.

New therapeutic approaches for Pompe disease: enzyme replacement therapy and beyond.

Kishnani PS, Beckemeyer AA.

Pediatr Endocrinol Rev. 2014 Sep;12 Suppl 1:114-24. Review.

PMID:
25345093

Supplemental Content

Support Center